Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(webinar)
253 results
  • Put an End to Missed Opportunities. [Journal Article]
    Prof Case Manag 2019 Nov/Dec; 24(6):277-279Daniels S
  • The ongoing transformation of America's health care system is bringing disruption in every sector of our industry. Hospital case management programs are similarly undergoing dramatic changes as care coordination for our most vulnerable patients becomes the focus of many hospital case management programs. As a result, case management leaders and human resource directors are disrupting legacy assum…
  • Biological implications of clonal hematopoiesis. [Review]
    Exp Hematol 2019Luis TC, Wilkinson AC, … Shlush LI
  • Adult hematological malignancies, such as acute myeloid leukemia, are thought to arise through the gradual acquisition of oncogenic mutations within long-lived hematopoietic stem cells (HSCs). Genomic analysis of peripheral blood DNA has recently identified leukemia-associated genetic mutations within otherwise healthy individuals, an observation that is strongly associated with age. These geneti…
  • Factors influencing credentialing of interventionists in the CREST-2 trial. [Journal Article]
    J Vasc Surg 2019Lal BK, Meschia JF, … CREST-2 Investigators
  • CONCLUSIONS: Identification of interventionists who were deemed sufficiently skilled for CREST-2 has required substantial oversight and a controlled system to judge current skill level that controls for specialty-based practice variability, procedural experience, and periprocedural outcomes. High-volume interventionists, particularly those with more recent experience, were more likely to be approved to participate in CREST-2. Primary approval was not affected by operator specialty.
New Search Next